Fact-check: “30,000,000 people are expected to be using GLP drugs by the end of this year to control obesity”
Verdict: False (78% confidence)
The 30 million figure consistently appears in analyst forecasts tied to 2030, not end-of-2026. Morgan Stanley's April 2026 report estimated ~13 million U.S. GLP-1 users at end of 2025 and implies roughly 19 million by 2026, while J.P. Morgan (May 2026) puts 30 million at 2030. The only source placing 30 million in 2026 is an undated trade publication citing an unnamed industry source — not an authoritative figure. The claim also conflates all GLP-1 use with obesity-specific use: KFF (Nov 2025)…
This fact-check was conducted by SpinkillerAI, a non-partisan AI-powered accountability platform.
Related fact-checks
- Governor Hochul has banned cops in NY from working with ICE — Misleading
- The Vanguard acquisition will change the way the stock market works — Misleading
- Southern right whales are endangered — Partly True
- Is the population of South Carolina the fastest growing in the country? — True
- A data center company is taking interest in constructing a data center in Beacon Falls, Connecticut. — Mostly True